http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106032534-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-115 |
| filingDate | 2015-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106032534-B |
| titleOfInvention | A kind of rna aptamer and its screening technique in conjunction with Non-small cell lung carcinoma cell-specific |
| abstract | The rna aptamer (RNA aptamer) and its screening technique that the present invention relates to a kind of in conjunction with Non-small cell lung carcinoma cell-specific.The present inventor is based in vivo in vivo-SELEX screening technique, and obtaining one can be with the rna aptamer (RNA aptamer) in conjunction with Non-small cell lung carcinoma cell-specific.The rna aptamer can be applied to and the combinations such as lung cancer chemotherapy drugs, siRNA, composition target medicine, to realize the targeted therapy of lung cancer.The rna aptamer and fluorescent dye etc. combine, and can prepare the diagnostic reagent of Non-small cell lung carcinoma. |
| priorityDate | 2015-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 48.